Researchers have developed a chip that analyzes a patient’s blood for cells shed by a lung cancer tumor, enabling treating physicians to determine whether lung cancer treatment is working by as early as the fourth week. The information provided by the chip would allow treatment to be adapted to meet patient’s needs and improve outcomes.Continue ReadingCategory: Medical, ScienceTags: Lung cancer, Treatment, Biomarkers, University of Michigan

Who Voted for this Story



Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz




Add to Technorati Favorites
Username:

Password:

Remember: